164 related articles for article (PubMed ID: 31854194)
1. Matrix matching in quantitative bioanalysis by LC-MS/MS a dream or a reality?
Heudi O; Winter S; Picard F
Bioanalysis; 2020 Jan; 12(2):67-69. PubMed ID: 31854194
[No Abstract] [Full Text] [Related]
2. IQ consortium perspective: complementary LBA and LC-MS in protein therapeutics bioanalysis and biotransformation assessment.
Kaur S; Bateman KP; Glick J; Jairaj M; F Kellie J; Sydor J; Zeng J
Bioanalysis; 2020 Feb; 12(4):257-270. PubMed ID: 32096432
[TBL] [Abstract][Full Text] [Related]
3. Strategies for effective development of ultra-sensitive LC-MS/MS assays: application to a novel STING agonist.
Fang K; Licea-Perez H
Bioanalysis; 2020 Apr; 12(7):467-484. PubMed ID: 32343151
[No Abstract] [Full Text] [Related]
4. Improving data integrity in regulated bioanalysis: proposal for a generic data transfer process for LC-MS from the European Bioanalysis Forum.
Arfvidsson C; Bedaf DV; Globig S; Knutsson M; Lewis M; McDougall S; Michi M; Timmerman P
Bioanalysis; 2020 Jul; 12(14):1033-1038. PubMed ID: 32706625
[TBL] [Abstract][Full Text] [Related]
5. Progress in high-sensitivity hybrid LC-MS/MS methods for the bioanalysis of protein drugs and performance tests for their validation.
Duggan JX
Bioanalysis; 2018 Jul; 10(13):983-986. PubMed ID: 29993264
[No Abstract] [Full Text] [Related]
6. Bioanalysis of therapeutic monoclonal antibody by peptide adsorption-controlled LC-MS.
Hashii N; Tousaka Y; Arai K; Enoki Y; Fukuda S; Goda R; Inoue N; Kawabata M; Murata K; Nakatsuji M; Okuzono T; Shigeyama T; Tachiki H; Yamaguchi T; Yamane S; Yamaoka M; Saito Y; Ishii-Watabe A
Bioanalysis; 2021 Feb; 13(4):265-276. PubMed ID: 33543661
[No Abstract] [Full Text] [Related]
7. Quantitative evaluation of the matrix effect in bioanalytical methods based on LC-MS: A comparison of two approaches.
Rudzki PJ; Gniazdowska E; Buś-Kwaśnik K
J Pharm Biomed Anal; 2018 Jun; 155():314-319. PubMed ID: 29684812
[TBL] [Abstract][Full Text] [Related]
8. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
de Dios K; Manibusan A; Marsden R; Pinkstaff J
J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
[TBL] [Abstract][Full Text] [Related]
9. Application of in-sample calibration curve methodology for regulated bioanalysis: Critical considerations in method development, validation and sample analysis.
Yuan L; Gu H; Zeng J; Pillutla RC; Ji QC
J Pharm Biomed Anal; 2020 Jan; 177():112844. PubMed ID: 31491659
[TBL] [Abstract][Full Text] [Related]
10. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects.
Van Eeckhaut A; Lanckmans K; Sarre S; Smolders I; Michotte Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2198-207. PubMed ID: 19179125
[TBL] [Abstract][Full Text] [Related]
11. Esterase inhibitors as ester-containing drug stabilizers and their hydrolytic products: potential contributors to the matrix effects on bioanalysis by liquid chromatography/tandem mass spectrometry.
Zheng N; Fung EN; Buzescu A; Arnold ME; Zeng J
Rapid Commun Mass Spectrom; 2012 Jun; 26(11):1291-304. PubMed ID: 22555922
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of a Therapeutic Antibody in Serum Using Intact Sequential Affinity Capture, Trypsin Digestion, and LC-MS/MS.
Vasicek LA; Spellman DS; Hsieh S; Seghezzi W; Zhang S; Santostefano M; Bateman KP
Anal Chem; 2018 Jan; 90(1):866-871. PubMed ID: 29206445
[TBL] [Abstract][Full Text] [Related]
13. Validation and application of hybridization liquid chromatography-tandem mass spectrometry methods for quantitative bioanalysis of antisense oligonucleotides.
Li P; Dupuis JF; Vrionis V; Mekhssian K; Magee T; Yuan L
Bioanalysis; 2022 May; 14(9):589-601. PubMed ID: 35545949
[No Abstract] [Full Text] [Related]
14. Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry.
van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):1-22. PubMed ID: 18701357
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a reliable LC-MS/MS method for quantitative analysis of usnic acid in Cladonia uncialis.
Sveshnikova N; Yuan T; Warren JM; Piercey-Normore MD
BMC Res Notes; 2019 Aug; 12(1):550. PubMed ID: 31470895
[TBL] [Abstract][Full Text] [Related]
16. How much separation for LC-MS/MS quantitative bioanalysis of drugs and metabolites?
Tan A; Fanaras JC
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():23-35. PubMed ID: 29558737
[TBL] [Abstract][Full Text] [Related]
17. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for quantitation of paralytic shellfish toxins: validation and application to reference materials.
Thomas KM; Beach DG; Reeves KL; Gibbs RS; Kerrin ES; McCarron P; Quilliam MA
Anal Bioanal Chem; 2017 Sep; 409(24):5675-5687. PubMed ID: 28730312
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a liquid chromatography tandem mass spectrometry assay for the measurement of faecal metronidazole.
Jeffery J; Vincent ZJ; Ayling RM; Lewis SJ
Clin Biochem; 2017 Apr; 50(6):323-330. PubMed ID: 27932283
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeutics.
Jenkins R; Duggan JX; Aubry AF; Zeng J; Lee JW; Cojocaru L; Dufield D; Garofolo F; Kaur S; Schultz GA; Xu K; Yang Z; Yu J; Zhang YJ; Vazvaei F
AAPS J; 2015 Jan; 17(1):1-16. PubMed ID: 25392238
[TBL] [Abstract][Full Text] [Related]
20. Comparison of conventional liquid chromatography-tandem mass spectrometry versus microflow liquid chromatography-tandem mass spectrometry within the framework of full method validation for simultaneous quantification of 40 antidepressants and neuroleptics in whole blood.
Steuer AE; Poetzsch M; Koenig M; Tingelhoff E; Staeheli SN; Roemmelt AT; Kraemer T
J Chromatogr A; 2015 Feb; 1381():87-100. PubMed ID: 25596763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
